Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

TD Cowen 45th Annual Health Care Conference

Mar 5, 2025 11:50 AM EST